NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV poses a higher risk of complications in adults, especially those with ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Dupixent ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

Sosei Heptares has taken another of its partnered G protein-coupled receptor (GPCR) programmes into mid-stage clinical trials, earning a $30 million milestone payment from Neurocrine Biosciences. The ...

Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

The role of acetylcholine in the central and peripheral nervous systems is well established in adults. Cholinergic modulation of vascular functions and body fluid balance has been extensively studied.

GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...

The corticosteroids market is driven by rising chronic diseases like asthma and COPD and innovations in drug delivery systems, enhancing treatment adherence. However, prolonged usage safety concerns ...